申请人:Ciba-Geigy Corporation
公开号:US04960787A1
公开(公告)日:1990-10-02
The invention relates to the pyrrolyl-substituted hydroxamic acid derivatives of the formula ##STR1## wherein R represents aryl, aryl-lower alkyl, cycloalkyl, bicycloalkyl or adamantyl; R.sub.1 and R.sub.2 represent hydrogen or lower alkyl; Y represents a direct bond, lower alkylene, lower alkenylene or lower alkadienylene; Z represents ##STR2## wherein R.sub.3 represents hydrogen or acyl; R.sub.4 represents lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, aryl or aryl-lower alkyl; or Z represents ##STR3## wherein R.sub.3 represents hydrogen or acyl; R.sub.5 represents lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, aryl, aryl-lower alkyl, amino or N-(mono- or di-lower alkyl)-amino; R.sub.6 and R.sub.7 represent hydrogen or lower alkyl; and pharmaceutically acceptable salts thereof provided that R.sub.3 represents hydrogen; which are useful as lipoxygenase inhibitors.
本发明涉及式I所示的吡咯烷基取代的水杨酰胺衍生物,其中R代表芳基、芳基-低级烷基、环烷基、双环烷基或金刚烷基;R1和R2代表氢或低级烷基;Y代表直接键、低级亚烷基、低级亚烯基或低级亚二烯基;Z代表式II,其中R3代表氢或酰基;R4代表低级烷基、C3-C7环烷基、芳基或芳基-低级烷基;或者Z代表式III,其中R3代表氢或酰基;R5代表低级烷基、C3-C7环烷基、芳基、芳基-低级烷基、氨基或N-(单或二低级烷基)氨基;R6和R7代表氢或低级烷基;以及当R3代表氢时,所述化合物的药用可接受盐,这些化合物作为脂氧合酶抑制剂是有用的。